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Abstract 
Ventricular repolarization dynamics are crucial to arrhythmogenesis. Low-frequency 
oscillations of repolarization have recently been reported in humans and the 
magnitude of these oscillations proposed to be a strong predictor of sudden cardiac 
death. Available evidence suggests a role of the sympathetic nervous system. We 
have used biophysically detailed models integrating ventricular electrophysiology, 
calcium dynamics, mechanics and β-adrenergic signaling to investigate the 
underlying mechanisms. The main results were: (1) Phasic beta-adrenergic 
stimulation (β-AS) at a Mayer wave frequency between 0.03 and 0.15 Hz resulted in 
a gradual decrease of action potential (AP) duration (APD) with concomitant small 
APD oscillations. (2) After 3-4 minutes of phasic β-AS, the mean APD adapted and 
oscillations of APD became apparent. (3) Phasic changes in haemodynamic loading 
at the same Mayer wave frequency (a known accompaniment of enhanced 
sympathetic nerve activity), simulated as variations in the sarcomere length, also 
induced APD oscillations. (4) The effect of phasic β-AS and haemodynamic loading 
on the magnitude of APD oscillations was synergistic. (5) The presence of calcium 
overload and reduced repolarization reserve further enhanced the magnitude of APD 
oscillations and was accompanied by afterdepolarizations and/or spontaneous APs. 
In conclusion, low-frequency oscillations of repolarization recently reported in 
humans were induced by phasic β-AS and phasic mechanical loading, which acted 
synergistically, and were greatly enhanced by disease-associated conditions, leading 
to arrhythmogenic events. 
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We have recently reported that ventricular action potential (AP) duration (APD) 
in humans may oscillate at frequencies of the sympathetic nerve rhythm, between 
0.03 and 0.15 Hz [1]. However, the mechanism underlying these phasic APD 
changes is at present unclear. Coherence analysis showed that the presence of 
these APD oscillations was related to the presence of low-frequency haemodynamic 
oscillations of blood pressure (BP) known as Mayer waves [1]. Changes in 
haemodynamic loading are well known to modulate APD through the process of 
mechano-electric feedback, whereby changes in myocardial stress / strain alter the 
electrophysiology [2]. Changes in ventricular APD in response to transient changes 
in ventricular loading have been demonstrated in humans [3]. Oscillations of BP at 
the Mayer frequency range are generally thought to be due to phasic changes in 
peripheral resistance and vasomotor tone [4]. Mayer waves are reduced or abolished 
by α-adrenergic blockade and enhanced in the presence of increased sympathetic 
nerve activity [4]. The above considerations therefore suggest a role of the 
sympathetic nerve activity in generating the APD oscillations, either directly through 
a β-adrenergic action and /or through the intermediary of mechano-electric coupling.  
Sympathetic nerve stimulation modulates ventricular APD as a result of the net 
effect on a number of membrane currents, in particular the L-type calcium current 
(ICaL) and the slowed delayed rectifier potassium current (IKs) [5]. We have used 
computational modeling to examine the possibility that phasic β-adrenergic 
stimulation (β-AS) at frequencies in the Mayer wave range might induce 
corresponding phasic changes in APD. Initial observations suggested that this was 
not the case in accordance with the slow phosphorylation and dephosphorylation 
kinetics of cellular protein kinase A (PKA) substrates. However, when phasic β-AS 
was prolonged, APD oscillations at the simulated frequency developed. In view of 
the relation between APD oscillations and the presence of BP oscillations (Mayer 
waves) in intact humans [1], we next examined the hypothesis that APD oscillations 
might be secondary to BP oscillations inducing phasic changes in ventricular loading 
and modulating APD through changes in intracellular calcium and the opening of 
mechano-sensitive ion channels. As mechano-electric coupling (MEC) [2] has been 
shown to be potentiated by β-AS [6], we then examined the effect of cyclical 
haemodynamic changes in the presence of enhanced background β-AS on APD. 
Finally, we investigated the effect of calcium (Ca2+) overload and reduced 
repolarization reserve (RRR), both commonly associated with disease and both well 




2.1  Human data 
 
We previously reported the presence of oscillations of ventricular APD in the 
Mayer wave frequency range in humans [1] (Figure 1). The methodology has been 
described in detail in [1], in brief: 14 ambulatory patients with heart failure with 
biventricular pacing devices were studied while watching movie clips to enhance 
arousal. Unipolar electrograms were recorded from the left ventricular epicardial 
electrode of the device while cycle length (CL) was maintained constant by right 
ventricular pacing from the device. Activation recovery intervals (ARIs) were 
measured from electrograms as a conventional surrogate for APD [7]. BP was 
measured non-invasively (Finapress). Oscillations were quantified using time-
frequency and coherence analysis. Oscillations in systolic (as well as diastolic) BP at 
the Mayer wave frequency (0.03 - 0.15 Hz) were observed in all patients. In 6 
patients (43%), Mayer wave frequency oscillations were also detected in the APD 
(ARI). Oscillations in APD and systolic BP (diastolic BP, respectively) were 
significantly coupled in all patients where these could be measured. 
 
2.2 Ventricular cell electrophysiological models 
 
The O’Hara human ventricular AP model [8], developed based on human 
undiseased data, was used as a basis to represent the electrophysiology of 
epicardial cells. As in previous studies [9], the formulation for the fast sodium current 
in the O’Hara model was replaced with an alternative one, in this case adopted from 
the ten Tusscher human ventricular model [10], which allows for further use of the 
model if electrical propagation in tissue wants to be simulated.     
For confirmation of some of the results obtained with the O’Hara model, the ten 
Tusscher human ventricular epicardial model was additionally used. Similarly to 
other modelling studies [11], the formulation for the Na+/Ca2+ exchange current 
(INaCa) was taken from [12], with the parameter values reported therein, which 
resulted from fitting experimental data from non-failing human hearts. In contrast to 
the original formulation, the utilized one includes allosteric activation by Ca2+. In 
analogy, the same formulation for the INaCa current proposed in [12] was adopted for 
the O’Hara model, which originally included a mechanistically novel formulation to try 
to reproduce the non-failing human ventricular data presented by Weber et al. [12].   
AP models representative of other animal species were additionally used in the 
present work to confirm simulation results in other species and verify model 
independence. These included the Decker model for dog [13] and the Shannon 
model [14] for rabbit. Also, the Negroni rabbit model integrating ionic, contractile and 
β-AS formulations [15] was employed for specific simulations, being its 
electrophysiological description based on the Shannon model. The integrative 
Terkildsen rat model combining the Pandit-Hinch model for the electrophysiology-
Ca2+ dynamics with the Niederer model for the mechanics was additionally employed 
[16].  
 
2.3 PKA phosphorylation 
 
PKA phosphorylation effects were included in the models using two different 
approaches. The first one, defined in [17], uses subpopulations of phosphorylated 
and non-phosphorylated channels for each substrate affected by β-AS. At each time 
instant, the total current or flux was computed as a weighted average of the two 
subpopulations, with the fraction of phosphorylated channels being determined by 
the β-adrenergic cascade, as defined in [17]. The properties of the non-
phosphorylated channels were described by the baseline electrophysiological model 
for either human or dog [8, 13], while the properties of the phosphorylated channels 
were determined from experimental data for a saturating dose of the β-adrenergic 
agonist isoproterenol (ISO), as defined in [18] for human and [17] for dog.  
The second approach, defined in [19] and subsequently updated in [5, 15], 
describes PKA-mediated phosphorylation of cellular targets with definition of graded 
and dynamic phosphorylation levels. In the simulations coupling the human O’Hara 
AP model with the β-adrenergic signaling model updated in [5], an extension of the 
approach described in [20] was considered to account for additional PKA substrates. 
IKs phosphorylation and dephosphorylation rate constants were slowed down with 
respect to those used in [19] to account for recent experimental observations [21], as 
in [5]. PKA-mediated phosphorylation of phospholemman (PLM) was described by 
increasing the Na+–K+-ATPase (NKA) affinity for intracellular Na+ [5]. RyR 
phosphorylation was defined as in [17]. In the simulations involving rabbit ventricular 
models [19, 15], the formulations reported in the respective studies were used, with 
IKs phosphorylation and dephosphorylation rate constants being also slowed down 
when including PKA effects in the Shannon rabbit model [19]. 
The two PKA phosphorylation models described above will be generally 
referred as Heijman and Xie models, respectively. Note that two different PKA 
models (one originally developed for dog and the other one for rabbit) were used to 
confirm that, independently of how phosphorylation effects were represented in the 
models, the conclusions on the role of β-AS in modulating APD oscillations were still 
valid. 
 
2.4 Electromechanical cell models 
 
The human ventricular electrophysiological models described in 2.2 were 
coupled to a modified version of the Niederer active contraction model [22]. This 
modified version (modNiederer model) includes a description of sarcomere length 
(SL) variation during the cardiac cycle, developed based on physiological patterns 
published in the literature [23] obtained using tagged magnetic resonance images of 
the short and long axis of the heart during pacing [24, 25]. Similar descriptions have 
been used in other studies [26]. Figure S1 in the Supplementary Material shows the 
stretch ratio λ for this model, with λ representing SL normalized by resting SL. The 
modNiederer contraction model was adjusted to human cell characteristics following 
an approach similar to that described in [26], which involved modifications in the 
relaxation rates αr1 and αr2 to account for increases in these rates under higher body 
temperatures as well as modifications in the parameters Tref and Ca50ref determining 
contractile tension.  
For confirmation purposes, the Niederer contraction model, with the same 
adjustments to human characteristics, was used. Additionally, a set of simulations 
was run with electromechanical cell models obtained from coupling human AP 
models with the Rice model of myofilament dynamics [27].  
In the coupled electromechanical models, the free cytoplasmic Ca2+ 
concentration computed according to the electrophysiological model served as an 
input for the mechanical model. The mechanical model, in turn, fed back the amount 
of Ca2+ buffered to troponin, computed as a function of SL, into the 
electrophysiological model (details can be found in the Supplementary Material).  
Finally, the integrated Negroni rabbit model [15] referred to in section 2.2 was 
used to investigate the joint electrical and mechanical cellular response to β-AS. In 
particular, the Negroni model incorporates β-AS effects on properties like 
myofilament Ca2+ sensitivity and titin stiffness as well as cross-bridge cycling rate 
[15]. The use of this model allows dissecting the contribution of β-AS-induced effects 
on myofilament properties to APD oscillatory behavior separately from the 
contribution of β-AS-induced effects on ionic currents and fluxes. 
A list of all the combined models used in the present study integrating 
electrophysiological, PKA and/or mechanical formulations is presented in Table 1 
together with the phenomena they are used to investigate and the reason for their 
introduction. The primary combined model used in this study is the O’Hara-Xie-
modNiederer model. The O’Hara model is the most up-to-date human ventricular 
electrophysiological model, developed based on newly recorded human undiseased 
data. The Xie model, with incorporated updates as explained in section 2.3, 
describes PKA phosphorylation taking into account differential non-steady state 
kinetics of phosphorylation targets. The modNiederer model is based on the 
mechanical Niederer model, with parameter value modifications to represent human 
characteristics and with incorporation of SL variation during the cardiac cycle based 
on physiological patterns, as described in the first paragraph of this subsection. 
Several of the combined models listed in Table 1 are representative of animal 
species rather than human. Even if the main interest of this study is in the use of 
human models, also because the experimental data used for comparison comes 
from humans, we used animal models for confirmation of the main findings and 
mechanisms. Some of the utilized human models were originally developed for other 
species and have been subsequently adapted to human, thus corroboration of the 
simulated results using models specifically developed for rabbit, dog or rat provides 
additional value to the obtained outcomes.  
 
2.5 Stretch-activated channels  
Stretch-activated channels (SACs) were introduced in the above described 
electromechanical cell models. ISAC was defined as the total current through both K+-
selective and non-specific cationic SACs.  
Similarly to other electromechanical models published in the literature [28, 29], 
a linear time-independent formulation was used for the current through non-selective 
cationic SACs:  
ISAC,ns = GSAC,ns  ((λ-1)/(λmax-1))  (V-ESAC,ns),     if λ>1 
ISAC,ns = 0,         if λ≤1 
where λ is the ratio between SL and the resting SL defined in the model and λmax is 
set to 1.1 as in [26, 28]. The reversal potential ESAC,ns was set to -10 mV based on 
experimental evidence [30, 31]. Provided the wide range of conductances reported 
for these channels, we considered both low (0.002 nS/pF) and high (0.006 nS/pF) 
GSAC,ns conductance values. Additionally, in accordance with publications reporting 
higher stretch-sensitivity of these channels in disease, as e.g. in hypertrophied 
versus control myocytes [30], GSAC,ns was set to 0.01 nS/pF when simulating disease 
conditions associated with Ca2+ overload or RRR. All the above GSAC,ns values lie 
within the limits reported in the literature [32, 33].    
The current through K+-selective SACs was modeled as an outwardly-
rectifying current [28, 29] with parameter values obtained from the experimental 
fitting reported in [29]:  
ISAC,K = GSAC,K  ((λ-1)/(λmax-1))  (1/(1+exp((V-19.05)/29.98))),  if λ>1 
ISAC,K = 0,         if λ≤1 
The conductance GSAC,K was set to match experimental current values measured in 
epicardium [34], as in [29]. 
 
2.6 Computational simulations 
 
Pacing protocol: Numerical experiments were performed to investigate the 
individual and collective effects of phasic β-AS and stretch. Virtual cells were paced 
at a basic CL of 1 s, although other cycle lengths varying between 0.5 and 1.5 s 
were additionally explored. In each simulation, steady state initial conditions were 
used, which were obtained after having paced the cell at the simulated CL for a 
thousand beats. The stimulus current magnitude and duration were defined as 
originally described for each model. APD was measured at 90% repolarization.  
Phasic β-AS: Phasic β-AS at a specified Mayer wave frequency φ between 0.03 
and 0.15 Hz was simulated by stimulating the cell with isoproterenol (ISO) following 
periodic stepwise variations in which ISO was present at a fixed concentration during 
half of the Mayer wave period and was absent in the other half, in line with reported 
patterns of muscle sympathetic nerve activity during sympathetic activation [35]. An 
ISO level of 1 µM, corresponding to maximal β-AS effects, was used for the 
simulations, but other levels of 0.01 and 0.1 µM were also tested.  
Phasic haemodynamic loading: Phasic changes in haemodynamic loading at a 
Mayer wave frequency φ were investigated using the modNiederer, Niederer and 
Rice mechanical models. Using the modNiederer model, simulations were run in 
which the end-diastolic value of the stretch ratio λ was varied along cardiac cycles 
following a sinusoidal waveform of frequency φ and maximal value of 1.1 
corresponding to 10% stretch, in line with percentages tested in other studies [36]. 
The effect of a lower stretch level (5%) was additionally evaluated. The sinusoidal 
shape is in line with experimentally observed pressure variations during sympathetic 
activation [1]. Additionally, simulations were run in which the end-systolic value of the 
stretch ratio λ was sinusoidally varied along cardiac cycles. For confirmation 
purposes, in a set of simulations the Rice myofilament model [27] was used and the 
effects of variations in SL were analyzed following a similar procedure. Also, the 
Niederer model (not including SL variations within the cardiac cycle) was used to 
assess the effects of phasic sinusoidal changes in SL along time. 
Combined phasic β-AS and haemodynamic loading: Combined phasic changes 
in β-AS and haemodynamic loading were evaluated, with different delays between 
one and the other action being defined. The range of simulated delays covered from 
concomitant to completely out-of-phase β-AS and stretch changes. 
Mayer wave frequencies: A range of Mayer wave frequencies (0.03 - 0.15 Hz) 
were considered for simulation of phasic β-AS and haemodynamic loading, in 
accordance with the data reported in [1], of which representative sets are presented 
in Figure 1. Graphical results are shown in the present work for φ = 0.05 Hz. Results 
for other frequencies, φ = 0.03 Hz and 0.1 Hz, are reported in the text.  
APD oscillation magnitude: In all cases where APD oscillated around a given 
value, the magnitude of the oscillations was quantified as the peak-to-peak 
amplitude of the APD series. Specifically, the peak-to-peak APD amplitude was 
computed in five consecutive oscillation periods and the maximum of the five 
amplitudes was calculated. This quantity was denoted by mAPD. 
Simulation of disease conditions: In addition to models representing normal 
physiology, disease conditions associated with Ca2+ overload and RRR were 
simulated. Ca2+ overload was modeled by increasing the extracellular calcium 
concentration (Cao) [37, 38] to different extents corresponding to amplification 
factors of 1.5, 2, 2.5 and 4. Additionally, other forms of inducing Ca2+ overload were 
simulated by attenuating the activity of the Na+/K+ pump through a decrease in its 
maximal conductance or an increase in its intracellular sodium (Nai) half-saturation 
constant [39, 40, 41, 42]. RRR conditions were simulated by simultaneously 
inhibiting the fast and slow delayed rectifier potassium currents, IKr and IKs, [43] by 
up to 30% and 80%, respectively [18]. Simulations were carried out to evaluate how 
Ca2+ overload (analogously, RRR) altered the magnitude of APD oscillations and to 
assess whether these alterations were modulated by the interaction with the 
adrenergic action, the stretch action or both. Specifically, APD oscillations were 
induced by β-AS, stretch and the combination of the two under physiological as well 
as under Ca2+ overload (analogously, RRR) conditions and their magnitudes were 





3.1 Short phasic β-AS does not initiate APD oscillations at Mayer wave 
frequencies 
 
Immediately following a period of enhanced β-AS, global shortening of the APD 
was observed. This is illustrated in Figure 2, where the upper panel shows the time 
series of periodic ISO application and the lower panel shows the corresponding APD 
response calculated with the coupled O’Hara-Xie-modNiederer model. In each 20-
second period APD prolongation and shortening were observed, with the amount of 
APD prolongation being small compared to the more pronounced APD shortening. 
As can be seen from the figure, the global APD shortening trend dominated and 
masked concomitant oscillatory behavior in the APD.  
 
 
3.2 Prolonged phasic β-AS induces low-level APD oscillations at Mayer wave 
frequencies 
 
After a prolonged interval of enhanced β-AS, phosphorylation levels of all 
cellular substrates were seen to effectively oscillate. Figure 3A shows 
phosphorylation levels computed with the Heijman (left panel) and Xie (right panel) 
signaling models, with the specific modifications described in section 2.3. Time 0 
corresponds to the start time of phasic β-AS (ISO varying between 0 and 1 µM in 20-
second periods as in Figure 2). In each of the two models, large differences between 
the phosphorylation kinetics of modeled cellular substrates can be appreciated, with 
some of them, like IKs, presenting very slow trends as compared to other substrates 
with very fast dynamics. This underlies the fact that the APD takes some time (3-4 
minutes) to start oscillating following enhanced β-AS. 
The effects of prolonged phasic β-AS on human ventricular APD are presented 
in Figure 3B for the O’Hara-Xie-modNiederer model. APD oscillations of 4-5 ms in 
magnitude developed in response to prolonged phasic changes in ISO 
concentration. Phosphorylation levels of PKA targets are presented together with the 
three currents associated with the targets having the largest contribution to APD, 
particularly ICaL and IKs. While all substrates oscillated with a 20-second period, 
phosphorylation-induced increase in ICaL absolute magnitude following each ISO 
application was faster than the corresponding increase in IKs (Figure 3B, insets). This 
mechanism underlies the initial APD prolongation observed at the beginning of each 
β-AS period (ISO varying from 0 to 1), which was subsequently followed by APD 
shortening as IKs phosphorylation started taking more relevance. Similarly, faster 
changes in ICaL as compared to IKs upon ISO returning to 0 (Figure 3B, insets) 
served to explain early APD shortening followed by successive prolongation.  
Prolonged phasic β-AS induced APD oscillations also for other AP models and 
PKA formulations. For the O’Hara-Heijman-modNiederer model, the magnitude of 
human APD oscillations was 2-3 ms, although the kinetics during the first minutes 
after the start of phasic β-AS were substantially different from those of the O’Hara-
Xie-modNiederer model due to differences between the Heijman and Xie 
phosphorylation descriptions (Figure 3A). For coupled electrophysiological and β-
adrenergic signaling models representative of other animal species, the magnitude 
of the oscillations induced by prolonged phasic β-AS varied from 2 ms for the canine 
Decker-Heijman model to 8 ms for the rabbit Shannon-Soltis model.     
 Additionally, the dependence of APD oscillations’ characteristics on the 
pacing frequency and on β-AS frequency and strength were tested. In all cases APD 
oscillations could be appreciated, with their magnitude increasing for larger ISO 
concentrations (β-AS strength) and decreasing for higher pacing and β-AS 
frequencies. An oscillation range was quantified for the O’Hara-Xie-modNiederer 
model, spanning from 1 ms for a pacing CL of 0.5 s, Mayer wave frequency of 0.1 Hz 
and ISO concentration of 0.01 µM  to 7 ms for corresponding values of 1.5 s CL, 
0.03 Hz Mayer frequency and 1 µM ISO. This range of APD oscillations lies within 
the values reported in [1] for low-frequency ARI oscillations evoked by mental 
arousal, covering the low to middle reported range.  
 Results corresponding to the assessment of whether β-AS effects on 
myofilament properties could add to the magnitude of APD oscillations observed 
after prolonged phasic stimulation are presented in Figure 4. As illustrated in the 
figure for APs calculated with the Negroni model, removing ISO effects from 
myofilaments led to APD oscillations of a magnitude comparable to that obtained 
when ISO effects on all ion fluxes and myofilaments were included (5.4 vs 5.8 ms). 
While a number of alterations could be observed after removing ISO effects on 
myofilaments, including a reduction in peak systolic calcium, preservation of peak 
force and an increase in contraction duration (Figure 4, lower three panels), this only 
had a minor impact on APD fluctuations (Figure 4, second upper panel). It is also 
interesting to note that, even if this model reproduces the ISO-induced APD 
shortening reported experimentally at steady state, a transient APD prolongation 
lasting for more than 10 seconds occurred following each ISO application. This 
explains why after a prolonged interval of phasic β-AS, the APD lengthened during 
each ISO phase and, analogously, shortened during the phase of ISO absence 
(Figure 4, second upper panel).  
 
3.3 Phasic stretch changes contribute to APD oscillations at Mayer wave 
frequencies  
 
Simulation of phasic changes in SL, associated with changes in haemodynamic 
loading accompanying enhanced sympathetic activity, led to almost immediate 
oscillations in the APD. Figure 5 presents the results of simulating 20-second period 
variations in end-diastolic SL for the O’Hara-Xie-modNiederer model in the absence 
of β-AS. Three different results are shown, corresponding to two cases where SACs 
are included in the model and one case where SACs are not modeled. When SAC 
effects were not considered (Figure 5, black line), stretch (represented by the stretch 
ratio λ in the first panel) increased the amount of Ca2+ bound to troponin C (CaTrop, 
third panel) and decelerated the decay of such a concentration. This, in turn, caused 
a reduction in the free cytosolic Ca2+ concentration (fourth panel) and, as a 
consequence, there was an increase in the outward (reverse-mode) and a decrease 
in the inward (forward-mode) Na+/Ca2+ exchanger current (INaCa, fifth panel). All 
together those alterations led to APD shortening (second panel). Similarly, distension 
led to APD prolongation. Therefore, APD oscillated with the same 20-second period 
in response to phasic 10% stretch changes, being the magnitude of the oscillations 
of around 7 ms. To confirm that these observations were independent of the 
employed electrophysiological model, the simulation was repeated using the ten 
Tusscher human ventricular model coupled to the same modNiederer active 
contraction model. APD oscillations of 6 ms were observed and the aforementioned 
mechanisms were corroborated, thus confirming independence of the chosen model. 
Additionally, the Terkildsen rat model was shown to yield similar results in terms of 
stretch-induced APD oscillations and associated mechanisms, with the only 
difference being the lack of stretch-induced changes in the outward INaCa current 
despite a similar reduction in inward INaCa. In this rat model the maximum amplitude 
of APD oscillations was of 8 ms.  
The contribution of SACs to APD oscillations was assessed for low (GL = 0.002 
nS/pF) and high (GH = 0.006 nS/pF) conductance non-selective cation channels. 
The stretch-induced changes in Ca2+ dynamics and INaCa current tended to shorten 
the APD, an effect that in the GL case was magnified after introducing ISAC as a 
result of the large outward current through ISAC,K and partially through ISAC,ns (Figure 
5, green line). The magnitude of APD oscillations in that case increased up to 10.0 
ms. In the GH case (Figure 5, red line), however, the inward current through non-
cation SACs became substantially more relevant and contributed to stretch-induced 
APD prolongation, overcoming the shortening effect induced by stretch in the 
absence of ISAC. In this case, the APD oscillation magnitude was as high as 11.8 ms.   
In addition to the effect of non-selective SAC conductance, the magnitude of 
low-frequency APD oscillations was also found to be dependent on the stretch level. 
For 5% stretch, APD fluctuations spanned from 3.6 ms to 5.0 ms, depending on the 
value of GSAC,ns. The variability in the magnitude of APD oscillations for simulated 
5% and 10% stretch levels and different SAC conductances is in line with the wide 
spectra of APD fluctuations reported in [1] (see e.g. Figure 1).  
Furthermore, the effect of varying end-systolic SL shortening was assessed 
using the O’Hara-Xie-modNiederer model. Results confirmed that, in agreement with 
previous experimental observations [44], the impact on APD oscillations was little 
(below 2 ms) even for large simulated variations.  
The reported results on the contribution of haemodynamic loading changes to 
APD oscillatory behavior were confirmed by coupling the human ventricular AP 
models (O’Hara and ten Tusscher models) with the Niederer model and/or the Rice 
myofilament model. Phasic sinusoidal changes in end-diastolic sarcomere length led 
to almost immediate APD oscillations, in agreement with the results obtained when 
the modNiederer model was used. For 10% stretch, the Niederer and modNiederer 
models led to similar magnitudes of APD oscillations (differences up to 1 ms), while 
the Rice myofilament model provided lower APD oscillation magnitudes than the 
modNiederer model (up to 5 ms below depending on ISAC,ns conductance). 
Simulation results using coupled electro-mechanical models with the Rice 
description for myofilament dynamics additionally confirmed that varying end-systolic 
SL shortening very slightly altered the APD (magnitude of APD oscillations less than 
2 ms).    
 
3.4 Combined phasic β-AS and stretch potentiate APD oscillations at Mayer 
wave frequencies 
 
Phasic β-AS and stretch concurred to amplify the magnitude of APD 
oscillations. Figure 6A shows APD oscillations (bottom panel), calculated with the 
O’Hara-Xie-modNiederer model, arising after a period of prolonged phasic β-AS (top 
panel) and stretch changes (middle panel). Both effects were simulated as periodic 
and concurrent in time, meaning that changes in ISO concentration started at the 
same time as those in the stretch ratio. The mechanisms underlying ISO-induced 
and stretch-induced electrophysiological alterations, described in 3.2 and 3.3, were 
observed to act synergistically to produce larger APD fluctuations.    
The comparison between the individual effects of prolonged β-AS (Figure 3B), 
individual stretch changes (Figure 5) and the combination of β-AS and stretch 
(Figure 6A) are summarized in Figure 6B for the O’Hara-Xie-modNiederer model. 
When SACs were not incorporated into the model, the magnitude of β-AS-induced 
APD oscillations was lower than that of stretch-induced ones and the conjunction of 
the two effects led to fluctuations of amplitude clearly larger than the individual 
amplitudes. In the presence of SACs the conjunction of β-AS and stretch enhanced 
the individual contributions or, at least, approximately maintained the largest one of 
the two (see Figure 6B). The same conclusion was reached when using the Niederer 
model instead of the modNiederer model.  
The temporal coordination of the two actions, β-AS and stretch, modulated APD 
oscillatory behavior. When β-AS and stretch acted in phase inducing APD 
oscillations that followed a similar temporal pattern (i.e. they induced simultaneous 
APD prolongation and shortening), a delay in one of the actions with respect to the 
other desynchronized the APD oscillations and resulted in a reduction in the 
oscillation amplitude. This occurred in the absence of SACs (where the reduction 
went from 9 ms for no delay to 7.5 ms for a 10-second delay) and in the case of 
SACs with GL conductance (with a reduction from 9.6 ms to 7.5 ms). However, in the 
case of SACs with GH conductance, an amplification of the individual effects was 
observed because a 10-second delay acted to synchronize the oscillations induced 
by β-AS and stretch (the oscillation magnitude varied from 11.9 ms to 17.6 ms). 
Similar results for concomitant and out-of-phase β-AS- and stretch-induced APD 
oscillations were observed with other models.   
Of note, the above reported ranges of low-frequency APD oscillations due to 
the combination of phasic β-AS and stretch changes are still in accordance with the 
APD fluctuation amplitudes reported in [1], examples of which are illustrated in 
Figure 1.   
 
3.5 Disease-related conditions involving calcium overload and reduced 
repolarisation reserve lead to magnification of APD oscillations and 
instabilities 
 
Low-frequency APD fluctuations induced by phasic β-AS and/or stretch were 
potentiated in Ca2+ overloaded myocytes. Figure 7A shows ∆ APD under different 
levels of Ca2+ overload, with ∆ APD calculated as a difference of each APD with 
respect to the minimum APD value. The presented results were obtained following 
prolonged phasic β-AS and stretch as in Figure 6A, using the O’Hara-Xie-
modNiederer model with GSAC,ns set to GH. As illustrated in the graphic, the higher 
the level of Ca2+ overload, the larger the oscillation magnitude.   
Our results showed that Ca2+ overload enhanced APD oscillations due to 
adrenergic stimulation as well as stretch. When produced as a result of stretch, this 
effect was amplified after including the contribution of SACs. Following an increase 
in extracellular Ca2+, changes in Ca2+ bound to troponin, free cytosolic Ca2+, IKs, ICaL, 
INaK or INaCa were observed. The magnitude of APD oscillations increased as a result 
of the variation in these currents and fluxes.  
Other approaches used for simulation of Ca2+ overload conditions, involving 
alterations in the activity of the Na+/K+ pump as described in section 2.6, led to very 
similar conclusions in terms of potentiation of APD oscillations as compared to 
physiological conditions. Illustration of the enhancement of APD oscillation 
magnitude under Ca2+ overload conditions simulated with those other approaches is 
provided in Figure S2 of the Supplementary Material. In this case, the magnification 
observed in Ca2+ overloaded myocytes was also more notable for stretch-induced 
oscillations after incorporating SACs into the models.  
RRR had a parallel impact on low-frequency APD fluctuations. Similarly to 
Figure 7A, Figure 7B shows ∆ APD induced by prolonged phasic β-AS and stretch 
under increasing degrees of IKr and IKs inhibition, which in turn led to gradually larger 
magnitudes of APD oscillation. Under RRR conditions, the magnification of APD 
oscillations was observed both when these were induced by β-AS or by stretch. 
Inhibition of the IKr current was identified as an important mechanism whereby RRR 
enhanced APD oscillations. IKr inhibition notably prolonged the AP and accentuated 
the contribution of other currents, like IKs or ISAC, to APD fluctuations in response to 
both phasic β-AS and stretch. In fact, simulation of RRR via inhibition of solely IKs by 
up to 80% did not result in any remarkable enhancement of APD oscillations, which 
maintained a magnitude similar to that under physiological conditions in response to 
β-AS, stretch (in the presence of SACs) or the combination of both. These results 
confirm that in those cases where IKs or ISAC,K are important drivers of APD 
oscillations, inhibition of IKr acts to potentiate their contribution.   
The combination of Ca2+ overload and RRR induced APD oscillations of larger 
magnitude than when RRR and Ca2+ overload were evaluated separately. Figure 7C 
summarizes the results corresponding to 20-second period APD oscillations induced 
by phasic β-AS and stretch under physiological conditions, Ca2+ overload (simulated 
by increasing Cao by a factor of 2.5), RRR (simulated by inhibiting IKr by 22.5 % and 
IKs by 60%) and the combination of the two latter ones. 
The enhancement of APD oscillations in Ca2+ overloaded and RRR myocytes 
was also observed for other coupled models. When the Heijman description for PKA 
phosphorylation of cellular substrates was used, phasic β-AS and stretch generated 
large APD fluctuations under concurrently simulated Ca2+ overload and RRR, as 
described above, subsequently leading to early afterdepolarizations (EADs). The 
observed afterdepolarizations were facilitated by the large current through non-
selective SACs, which contributed to augmentation of the net inward current and AP 
prolongation during repolarization. The main mechanism for EAD generation was 
reactivation of the ICaL current. The INaCa current, however, changed to the outward 
direction during the EAD depolarization, thus not contributing to its initiation. 
Confirmation of the ICaL role in EAD generation was provided by e.g. blockade of 
ICaL, which completely abolished EADs. Our observed mechanisms are in line with 
those reported for EAD triggering in other scenarios [45, 46]. 
When on top of RRR and Ca2+ overload, the conductance of non-selective 
SACs increased (GSAC,ns equal to 0.01 nS/pF), as reported for disease conditions 
[30], further electrical abnormalities were observed. Figure 8 compares the effects of 
continuous (top panel) vs phasic (bottom panel) β-AS, the latter additionally 
accompanied by phasic stretch changes. Transmembrane voltage was computed 
with the O’Hara-Xie-modNiederer model under the same high levels of Ca2+ overload 
and RRR in the two cases. APs before the start of β-AS are presented in the left 
column for comparison. After a brief period of β-AS, irregularities in the repolarizing 
phase of the AP appeared when stimulation was phasic and accompanied by 
stretch, but not when stimulation was continuous (middle column). A prolonged 
period of phasic, not continuous, stimulation led to EADs and EAD bursts (right 
column). As described in the paragraph above, the current through non-selective 
SACs augmented the net inward current and prolonged the AP, thus facilitating ICaL 
reactivation.  
Other coupled models used in the present study further corroborated the 
occurrence of electrical abnormalities induced by phasic β-AS and/or stretch under 
Ca2+ overload and RRR. Using the Negroni model, delayed afterdepolarizations 
(DADs) and spontaneous APs could be observed at increased Cao levels and 
reduced IKr and IKs currents. These were the result of myocyte’s Ca2+ overloading, 
which triggered an abnormal release of Ca2+ from the sarcoplasmic reticulum and 
activated the inward Na+/Ca2+ exchanger current to generate DADs and extra APs. 
Phasic β-AS accompanied by phasic stretch largely facilitated the occurrence of 
such abnormalities, as compared to constant β-AS, by lowering the levels of Ca2+ 





We have investigated the cellular mechanisms underlying phasic modulation of 
ventricular APD within the 0.03 - 0.15 Hz sympathetic nerve frequency, as recently 
reported in humans in vivo [1], using computational modeling. We employed cellular 
models coupling descriptions of ventricular electrophysiology, β-adrenergic signaling 
and mechanical contraction, mostly for human but also for other species like rabbit 
and dog. By using different models of human and other animal species we 
demonstrated that the presented results were largely model-independent. The main 
findings were: (1) Following the onset of phasic β-AS, a progressive decrease in 
APD was observed, which masked concomitant small APD oscillations. However, if 
phasic β-AS was continued for more than 3-4 minutes, APD oscillations at the β-AS 
frequency became apparent; (2) Phasic mechanical stretch at Mayer wave 
frequencies, simulating haemodynamic variations accompanying enhanced 
sympathetic activity, immediately resulted in APD oscillations; (3) The combination of 
phasic β-AS and mechanical stretch resulted in synergistic enhancement of APD 
oscillation; (4) In the presence of Ca2+ overload the magnitude of APD oscillation in 
response to combined phasic β-AS and mechanical stretch was enhanced in a dose 
dependent manner, and further enhanced with the addition of RRR (reduced IKr and 
IKs); (5) Electrical abnormalities in the form of afterdepolarizations and spontaneous 
APs were induced by phasic β-AS and stretch in myocytes with high levels of Ca2+ 
overload and RRR.  
Periodic repolarization dynamics at Mayer wave frequencies have recently 
been reported in a swine model and in humans [47]. On the basis of the known 
organization of sympathetic activity in a series of low frequency bursts [48, 35, 49] 
the authors examined the hypothesis that phasic sympathetic activation induces 
phasic changes in repolarization localized in the low-frequency spectral range. Using 
a measure of repolarization derived from the conventional electrocardiographic T 
wave they demonstrated periodic oscillation of repolarization at this frequency, which 
was enhanced by sympathetic activation and reduced by sympathetic blockade [47]. 
We have recently reported the presence of low-frequency oscillations at the level of 
the ventricular APD (measured as ARIs from unipolar electrograms) in ambulatory 
patients with heart failure during enhanced sympathetic activity [1]. In these patients, 
the presence of an implanted resynchronization device for biventricular pacing 
enabled recordings to be obtained directly from the left ventricular epicardium while 
simultaneously controling cycle length with right ventricular pacing. We are not 
aware of other studies in the literature, either in animal models or in humans, 
describing synchronization between ARI variations and Mayer waves.   
Experimentally, the effect of sustained β-AS is usually to shorten ventricular 
APD, although both APD increases and decreases have been reported [50, 51, 52]. 
A biphasic effect has recently been reported with an initial lengthening of APD 
followed after a few seconds by APD shortening [53, 21]. The initial lengthening was 
attributed to an early dominant effect of ICaL due to its more rapid onset kinetics, and 
the subsequent shortening due to the slower activating IKs [5, 53]. The initial effect of 
phasic β-AS in our simulations was a global trend of progressive APD shortening 
with alternate APD increases and decreases in response to the periodic β-AS, being 
the APD decreases much larger than the increases. Following each β-AS 
application, the APD initially prolonged during a few beats and subsequently 
shortened, in agreement with the above described experimental observations. The 
absence of oscillations around a fixed APD value is consistent with the slow 
phosphorylation and dephosphorylation kinetics of cellular PKA substrates. However, 
when phasic β-AS was prolonged, APD oscillations developed after 3-4 minutes, the 
time by which most PKA phosphorylation targets already reached its maximal 
phosphorylation level and started fluctuating around it. Our results are in good 
correspondence with the fact that, departing from basal conditions, enhanced β-AS 
has a large impact on ventricular electrophysiology, while after a period of prolonged 
β-AS adrenoceptors become less sensitive to the same stimulus than when they 
were in their basal state. 
The association that we observed between APD oscillations at 0.03 - 0.15 Hz 
frequencies and the presence of BP oscillations at the same frequency (Mayer 
waves) in humans [1] raises the possibility that MEC may play a role in the phasic 
modulation of APD. Oscillations in BP would be expected to reflect phasic changes 
in haemodynamic loading on the ventricular myocardium which may in turn influence 
APD on a beat-to-beat basis [2, 3]. The effect of MEC on APD is complex, 
depending on the nature of mechanical stretch / strain on the myocardial fibers, its 
timing in relation to the time course of AP repolarization and the extent of fiber 
excursion, and involving several cellular mechanisms including calcium cycling and 
SACs [54, 32, 55, 56, 57]. We simulated MEC by building biophysical models 
coupling electrophysiology and mechanics that include both direct and feedback 
mechanisms. In these models, the Ca2+ transient calculated from the 
electrophysiological model was the input for the mechanical model (direct pathway). 
In turn, the mechanical model was used to update Ca2+ dynamics as a function of 
the amount of Ca2+ bound to troponin C and, additionally, the current through SACs 
was incorporated into the ionic model subject to the stretch level defined in the 
mechanical model (feedback pathway). Using the described electro-mechanical 
models, APD oscillations at the same frequency of stretch-induced changes were 
established. Our simulations showed an additive effect of phasic β-AS and MEC on 
the magnitude of APD oscillations consistent with the known potentiating effect of β-
AS on mechanically induced changes in APD [6]. The mechanisms underlying APD 
oscillations under individual β-AS and stretch actions remained valid when the 
combination of the two was simulated, thus adding to the oscillation magnitude.     
Two commonly associated properties of the hearts of patients with ischemic 
heart disease, post myocardial infarction and cardiac failure are the presence of 
cellular Ca2+ overload and RRR [58]. Both are known to promote the development of 
afterdepolarizations and be pro-arrhythmic [58]. Our results showed that the 
presence of Ca2+ overload enhances the magnitude of APD oscillations induced by 
phasic β-AS and MEC. The magnitude of APD oscillations were further enhanced by 
the additional presence of RRR. This additional enhancement is related to the fact 
that loss of IKr in myocytes with simulated RRR allows uncovering the role of other 
currents, like IKs or ISAC, which notably contribute to APD oscillations induced by 
phasic β-AS, MEC or combined β-AS and MEC. Our results on the relationship 
between enhanced repolarization variability (in the form of low-frequency 
repolarization oscillations) and arrhythmogenesis in diseased hearts are in 
accordance with ECG studies showing an association between increased rate-
unrelated QT variability and arrhythmic risk [59, 60, 61]. It should be noted that in our 
study, as well as in the experimental data presented in [1], there is no additional 




Phasic β-AS and haemodynamic loading effects were simulated following 
stepwise and sinusoidal temporal patterns, respectively, in line with experimentally 
reported patterns of variation for muscle sympathetic nerve activity and blood 
pressure during sympathetic activation [35, 1]. Other types of temporal patterns of 
variation for simulated phasic β-AS and haemodynamic loading were tested (not 
shown), with the findings described in the present study remaining valid in all cases 
and only minor quantitative differences observed. Regarding the interaction of the 
two effects, phasic β-AS and myocardial stretch, simulations ranging from in-phase 
to completely out-of-phase cases were run and confirmation was obtained that the 
APD oscillations induced by one of the effects were not cancelled out by the other 
effect and, in most cases, the interaction was synergistic.    
Ca2+ overload conditions were simulated by three different means (involving 
increased Cao [37, 38] and reduced activity of the Na+/K+ pump [39, 40, 41, 42]) and 
in all cases magnification of APD oscillations was observed. The electrophysiological 
models used for these analyses, including the O’Hara and ten Tusscher human 
ventricular AP models [8, 10], led to APD prolongation in response to increased Cao. 
Future studies could explore whether the use of electrophysiological models showing 
APD shortening following increased Cao [62] still support the conclusions of the 
present study regarding magnified APD oscillations in Ca2+ overloaded myocytes. 
RRR was simulated by inhibition of both IKr and IKs currents and amplification of 
APD oscillations was noted. However, if RRR had been simulated by inhibition of 
solely IKs, APD oscillations of similar magnitude to those under physiological 
conditions had been observed for most of the simulated cases, i.e. in response to 
phasic β-AS, stretch in the presence of SACs and the combination of both.   
The present study was limited to single cells. Further studies should extend it by 
including tissue simulations built on the cellular simulations here presented. This 
would help to clarify how the mechanisms described in this study contribute to the 
electrical activity at the ventricular tissue level. Nevertheless, disease conditions like 
myocardial ischemia and heart failure result in cell-to-cell uncoupling and in those 
cases the results obtained in tissue would be expected to be closer to those in single 
cells, as investigated in this study. 
The experimental protocol used to record the human data used as a basis for the 
comparisons in this study [1] is known to induce heterogeneity in mechanical 
behavior throughout the left ventricle [24]. The left ventricular epicardial electrode 
used to record the unipolar electrograms is thus likely to experience notable pre-
stretch and larger than normal shortening. A potential increase in myocardial strain, 
on top of the emotionally-induced arousal elicited by watching movies, may have 
facilitated a rise in the observed magnitude of the low-frequency APD oscillations 
quantified in [1]. 
 
Implications 
Enhanced sympathetic activity is well known to be a major factor in 
arrhythmogenesis [63, 64]. Mechanisms include destabilization of repolarization and 
the generation of afterdepolarizations, and inhomogeneous changes of APD and 
refractoriness facilitating re-entrant arrhythmias. Oscillatory phenomena affecting the 
time course of ventricular repolarization are known to predispose to ventricular 
tachycardia and fibrillation [65, 58]. In this study, we have described mechanisms 
whereby sympathetic activity contributes to the establishment of pro-arrhythmic 
conditions through electromechanical interactions. While the results of this 
computational investigation must be considered of a somewhat preliminary nature, 
they nevertheless suggest that oscillations in ventricular APD at Mayer wave 
frequencies may play a role in arrhythmogenesis. In support of this suggestion is the 
result of two recently reported large patient cohorts showing that increased 
oscillatory behavior of ventricular repolarization at those frequencies, measured at 
the level of the ECG, was a strong predictor of cardiovascular mortality [47]. In one 
large cohort of post myocardial infarction patients it was the strongest single risk 
predictor of total mortality [47]. 
When extrapolating to the clinical situation several factors need to be taken 
into consideration. While oscillatory behavior is an inherent feature of sympathetic 
nerve activity over a range of frequencies [66], the physiological regulation of the 
Mayer waves engages other neurocardiovascular axes in addition to sympathetic 
regulation, which may contribute to haemodynamic and electrophysiological  
oscillations. For example, Mayer waves have been attributed to a central oscillator 
and/or to result from delay in the baroreflex loop [67, 68, 4]. A complex interaction 
has been shown to occur between Mayer wave oscillations, central respiratory drive 
and vagal nerve activity at the level of the brain stem nuclei [69]. 
 Studies in an ambulatory canine model of sudden death have shown an 
increase in sympathetic nerve activity prior to the onset of ventricular tachycardia 
and ventricular fibrillation [70]. Malignant ventricular arrhythmias were preceded by a 
progressive increase in low amplitude burst discharge and high amplitude spike 
discharge. Several of the illustrated examples of integrated nerve activity from that 
study show the presence of oscillations at the 10-second frequency [70] (Figures 4D 
and 4E, Figure 3B). However, several of the recordings do not show 10-second 
oscillation and the neural pattern preceding arrhythmias appears variable. We would 
propose that enhanced sympathetic activity may generate arrhythmias by several 
mechanisms such as described by Johnson et al. [71] and that oscillatory activity of 
APD when present may play a complementary role. 
 Studies in isolated myocytes and computer simulations during reduced 
repolarization reserve have shown that β-AS-induced calcium overload enhanced 
beat-to-beat APD variability and led to the development of early afterdepolarizations. 
[72, 71]. The mechanism was through intermittent spontaneous sarcoplasmic 
calcium release resulting in APD prolongation of the following beat due to reduced 
calcium deactivation of ICaL. These results suggest a random process underlying the 
development of early afterdepolarizations rather than an oscillatory process. 
However, in our studies while reduced repolarization reserve and β-AS-induced 
calcium overload were prerequisites for EAD development, a critical factor was the 
on / off nature of the stimulation. For example, if basal conditions are simulated and 
a sudden change in β-AS and stretch applied, EADs only occur during the initial 
transition, but, even if β-AS and stretch are continued, EADs no longer occur. In the 
case of phasic stimulation (β-AS and stretch), sudden changes in stimulation are 
continually applied and EADs perpetuate. The underlying mechanism relates to the 
different on / off time constants of calcium and potassium currents. We would 
envisage that the mechanisms described by Johnson et al. [71] and the phasic 
responses we describe here could coexist and act synergistically. Furthermore, it is 
generally considered that a function of oscillatory sympathetic nerve activity may be 
to create dynamic synchronization at effector end organs [73, 67]. It is possible 
therefore that oscillatory behavior of APD may produce spatio-temporal 
synchronization known to be important to overcome source sink mismatch and 
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Figure 1. Activation recovery interval (ARI), a standard surrogate for APD, oscillating 
at a frequency of 0.06 Hz (top), i.e. 18-second period, and 0.08 Hz (bottom), i.e. 13-
second period. Circles represent beat-to-beat ARIs, while solid lines represent low-
frequency trends. Power spectral densities (PSD) of ARI series are shown on the 
right hand side.  
Figure 2. Protocol of phasic isoproterenol (ISO) application (top panel) and 
corresponding time course of action potential duration (APD) changes (bottom panel) 
computed using the O’Hara-Xie-modNiederer model. 
Figure 3. A) Phosphorylation (Phosph) levels of PKA substrates elicited during a 
500-second protocol of isoproterenol (ISO) application like that shown in Figure 2, 
computed using the Heijman (left panel) and Xie (right panel) formulations described 
in section 2.3. In the left panel, fICaL, fIKs, fPLB, fTnI, fINaK, fINa, fIKur and fRyR 
denote the fractions of phosphorylated L-type calcium (ICaL), slowed delayed 
rectifier potassium (IKs), phospholamban (PLB), inhibitory troponin subunit (TnI), 
Na+/K+ pump (INaK), sodium (INa), ultrarapid plateau potassium (IKur) and 
ryanodine receptor (RyR) computed with the Heijman formulation. In the right panel, 
similarly for the Xie model, with fPLM and fICFTR denoting the fraction of 
phosphorylated phospholemman (PLM) and cystic fibrosis transmembrane regulator 
(ICFTR). B) Action potential duration (APD) oscillations at a frequency of 0.05 Hz 
(second row) following a period of prolonged phasic beta-adrenergic stimulation (first 
row), phosphorylation (phosph) levels of PKA substrates (third row) and time course 
of three currents (IKs, ICaL and INaK, last three rows) with major effects on the APD 
response to β-AS, as computed with the O’Hara-Xie-modNiederer model. In Figure 
3B, 0 in the x axis represents 270 s following phasic β-AS. 
Figure 4. Effects of prolonged phasic β-AS (first row, isoproterenol concentration 
(ISO)) on action potential duration (APD) oscillations at 0.05 Hz (second row) with 
PKA phosphorylation of all substrates (black) and with myofilament phosphorylation 
disabled (blue) in the Negroni model. In rows 3 to 5 corresponding time courses of 
free Ca2+ concentration (Cai), isometric force and sarcomere length (SL) are shown. 
0 in the x axis represents 270 s following phasic β-AS.  
Figure 5. Effects of prolonged phasic stretch of up to 10% (first row, stretch ratio (λ)) 
on action potential duration (APD) oscillations at 0.05 Hz (second row) in the 
absence (black, G0) and presence of stretch-activated channels (SACs) with low 
(green, GL) and high (red, GH) GSAC,ns (see section 2.4). Rows 3 to 5 illustrate how 
stretch increases the amount of Ca2+ bound to troponin (CaTrop), decreases the 
amplitude of free cytosolic Ca2+ (Cai) and causes a reduction in the inward Na+-Ca2+ 
exchanger current (INaCa) of the O’Hara-Xie-modNiederer model. These stretch-
induced changes, together with the contribution of SACs (sixth row, current through 
stretch-activated channels (ISAC)), modulate APD and lead to the observed cyclic 
changes. 0 in the x axis represents 270 s following phasic stretch. 
Figure 6. A) Effects of combined prolonged phasic β-AS (top panel, isoproterenol 
concentration (ISO)) and stretch (middle panel, stretch ratio (λ)) on action potential 
duration (APD) oscillations at 0.05 Hz (bottom panel) for the same three cases 
illustrated in Figure 5 corresponding to absence (black, G0) and presence of stretch-
activated channels (SACs) with low (green, GL) and high (red, GH) GSAC,ns. 0 in the x 
axis represents 270 s following phasic β-AS and stretch. B) Summary of the 
corresponding maximal magnitude of APD oscillations (mAPD) following prolonged 
phasic β-AS only, phasic stretch only and combined phasic β-AS and stretch in the 
O’Hara-Xie-modNiederer model.  
Figure 7. A) Magnitude of action potential duration (APD) oscillations (∆ APD) at 
0.05 Hz following prolonged combined phasic β-AS and stretch under Ca2+ overload 
conditions simulated by increasing extracellular Ca2+ concentration (Cao) by factors 
of 1.5 (dashed light grey), 2.0 (dotted dark grey) and 2.5 (solid black). B) Magnitude 
of APD oscillations (∆ APD) at 0.05 Hz under reduced repolarization reserve (RRR) 
conditions simulated by inhibiting the rapid and slowed delayed rectifier potassium 
currents, IKr and IKs, by 7.5% and 20% (dashed light grey), 15% and 40% (dotted 
dark grey) and 22.5% and 60% (solid black). C) Summary of maximal magnitude of 
APD oscillations (mAPD) for control, Ca2+ overload (Figure 7A), RRR (Figure 7B) and 
combined Ca2+ overload and RRR conditions. In all cases the O’Hara-Xie-
modNiederer model with high GSAC,ns was used. 0 in the x axis represents 270 s 
following phasic β-AS and stretch. 
Figure 8. Time course of transmembrane potential (V) at baseline (left column) and 
following brief (middle column) and prolonged (right column) periods of β-AS. 
Baseline corresponds to simulation of Ca2+ overload (4-fold increase in extracellular 
Ca2+) and RRR (30% IKr and 80% IKs inhibition). Constant β-AS with 1 µM ISO (first 
row) only slightly modifies the AP morphology, while phasic β-AS and stretch 
(second row) severely alter the AP leading to arrhythmogenic events. In these 
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Table 1. Combined electrophysiological, PKA and mechanical models used in this 
study. The first column indicates the effects investigated with the models and the 
sections containing the corresponding results in the text. The second column 
contains the name of the combined model as used in the text. The third, fourth and 
fifth column describe the individual electrophysiological, PKA and mechanical 
formulations assembled in the combined model. The sixth column justifies the 
reason for introducing each of the models in the study.   
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